Increased circulating vitamin d and testosterone levels in patients with cancer

HealthMED

Volumn 4, Issue 4 SUPPL. 1, 2010, Pages 1072-1075

  Fidan, Evren ^a   Yildiz, Bulent ^a   Yilmaz, Mustafa ^a   Ozdemir, Feyyaz ^a   Kavgaci, Halil ^a   Aydin, Fazil ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Lung neoplasms; Stomach neoplasms; Testosterone; Vitamin D

Indexed keywords

EID: 79851472672     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Osborne JE, Hutchinson PE. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol 2002;147: 197-213.
2. Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res 2009; 69: 1439-1447.
3. Ng K, Meyerhardt JA, Wu K, et al. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol 2008;26: 2984-2991.
4. Holland M, Rotenberg R, Gomez N, Marantz M, D'Angelo N. Serum testosterone: a possible marker for colorectal cancer. Medicina (B Aires) 1993;53:117-123.
5. Carey MA, Card JW, Voltz JW, Germolec DR, Korach KS, Zeldin DC. The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol Lung Cell Mol Physiol 2007;293: 272-278.
6. Green FL, Page DL, Fleming ID, editors. AJCC Cancer Staging Manuel. 6th ed. Newyork: Springer, 2002.
7. Kilkkinen A, Knekt P, Heliövaara M, et al. Vitamin D status and the risk of lung cancer: a cohort study in Finland. Cancer Epidemiol Biomarkers Prev 2008;17: 3274-3278.
8. Nakagawa K, Sasaki Y, Kato S, Kubodera N, Okano T. 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis 2005; 26:1044-1054.
9. Zhou W, Suk R, Liu G, et al. Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2005;14: 2303-2309.
10. Parise RA, Egorin MJ, Kanterewicz B, et al. CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer. Int J Cancer. 2006;119:1819-1828.
11. Jones G, Ramshaw H, Zhang A, et al. Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas. Endocrinology 1999; 140: 3303-3310.
12. Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst. 2007; 99: 1120-1129.
13. Bouillon R, Eelen G, Verlinden L, Mathieu C, Carmeliet G, Verstuyf A. Vitamin D and cancer. J Steroid Biochem Mol Biol. 2006;102: 156-162.
14. Hammoud Z, Tan B, Badve S, Bigsby RM. Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma. Endocr Relat Cancer. 2008;15: 475-483.
15. Schwartz AG, Prysak GM, Murphy V, et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res. 2005;11:7280-7287.
16. Radzikowska E, Langfort R, Giedronowicz D Estrogen and progesterone receptors in non small cell lung cancer patients. Ann Thorac Cardiovasc Surg. 2002;8: 69-73.
17. Zhou XD, Cai WQ, Cao HW. Ai Zheng. Relationship between level of sexual hormone in external blood and aromatase expression in cancer tissues of male patients with lung cancer 2002; 21: 259-262.